TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery
Clinical trial NCT03881878 · UNKNOWN
Trial details
- NCT number
- NCT03881878
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2022-10-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.